Company / Depreciation & Amortization
Kiniksa Pharmaceuticals International, plc Depreciation & Amortization History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.6M
FY2025
5-year range
$1.6M / $2.4M
FY2021-FY2025
Trend
-8.3%
vs FY2024
Sector context
#108 of 163
Health Care
What the data says
At $2M, Kiniksa Pharmaceuticals International, plc's depreciation & amortization ranks #56 of 163 in the Health Care sector. Depreciation & Amortization has declined for 3 consecutive years, from $2M in FY2022 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -8.4%.
Improved from $2M to $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -13.5%
- 5-Year CAGR
- -8.4%
- 10-Year CAGR
- -
Sector benchmark
#56 of 163 in Health CareTop 34% of 163This company $1.6M Sector average $219.4M
▼
-99.3% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's depreciation & amortization has declined for 3 consecutive years.
- 5-year CAGR of -8.4%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 8.3% year-over-year.
- Ranks #108 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6M | -8.3% |
| FY2024 | $1.7M | -27.6% |
| FY2023 | $2.3M | -2.5% |
| FY2022 | $2.4M | +16.2% |
| FY2021 | $2.1M | -14.0% |
| FY2020 | $2.4M | +16.3% |
| FY2019 | $2.1M | +623.1% |
| FY2018 | $286.0K | +921.4% |
| FY2017 | $28.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026